Description

Allocation of 5,25,000 equity shares to 6 anchor investors at ₹130 per share, raising ₹6.82 crore total, with NAV Capital VCC - Nav Capital Emerging Star Fund being the largest investor at 26.66%.

Summary

Ravelcare Limited (formerly Ravelcare Private Limited) announced the allocation of 5,25,000 equity shares to anchor investors at ₹130 per share (face value ₹10, premium ₹120) on November 28, 2025. The total amount raised from anchor investors is ₹6,82,50,000. Six anchor investors participated, with NAV Capital VCC - Nav Capital Emerging Star Fund receiving the largest allocation of 1,40,000 shares (26.66%). The company confirmed no applications were received from domestic mutual funds.

Key Points

  • Total anchor investor allocation: 5,25,000 equity shares
  • Anchor investor allocation price: ₹130 per share (face value ₹10 + premium ₹120)
  • Total funds raised from anchors: ₹6.82 crore
  • Number of anchor investors: 6
  • Largest investor: NAV Capital VCC - Nav Capital Emerging Star Fund (1,40,000 shares, 26.66%)
  • Five investors received equal allocation of 77,000 shares each (14.67% each)
  • No domestic mutual fund participation
  • Board approval date: November 28, 2025

Anchor Investor Details

  1. NAV Capital VCC - Nav Capital Emerging Star Fund: 1,40,000 shares (26.66%) - ₹1.82 crore
  2. Lighthouse Canton Special Opportunities Fund - I: 77,000 shares (14.67%) - ₹1.00 crore
  3. Viney Growth Fund: 77,000 shares (14.67%) - ₹1.00 crore
  4. Finvesta First: 77,000 shares (14.67%) - ₹1.00 crore
  5. J4S Venture Fund - I: 77,000 shares (14.67%) - ₹1.00 crore
  6. NAVbharat Investment Opportunities Fund: 77,000 shares (14.67%) - ₹1.00 crore

Company Information

  • Name: RAVELCARE LIMITED (Formerly Ravelcare Private Limited)
  • CIN: U20236MH2018PLC317628
  • Registered Office: Off-126, Neo Corporate Plaza, Cabin B, Ramchandra Lane Extension, Malad West, Mumbai-400064, Maharashtra
  • Email: ayush@ravelcare.com
  • Managing Director: Ayush Varma

Regulatory Changes

No regulatory changes announced. This is a standard disclosure required under SEBI IPO regulations for anchor investor allocation.

Compliance Requirements

  • Disclosure made to BSE as per IPO regulations
  • Information to be made public on BSE website
  • Anchor investor allocation finalized in consultation with Book Running Lead Manager
  • Board approval obtained for allocation

Important Dates

  • November 28, 2025: Board meeting held to finalize anchor investor allocation
  • November 28, 2025: Disclosure submitted to BSE

Impact Assessment

Market Impact: Limited to investors interested in Ravelcare Limited’s public issue. The anchor investor allocation represents the pre-IPO institutional commitment and provides price discovery for the main IPO.

Investor Impact: Anchor allocation at ₹130 per share sets the reference price for retail and other investors. The absence of domestic mutual funds may indicate limited institutional interest from this segment.

Operational Impact: Standard IPO process milestone. The successful anchor allocation allows the company to proceed with the retail portion of the public issue.

Impact Justification

Standard anchor investor allocation disclosure for IPO. Important for investors tracking the public issue but limited market-wide impact as it's a company-specific listing event.